USE OF AN ANTIBODY AGAINST THE SOLUBLE INTERLEUKIN 2 RECEPTOR α SUBUNIT CAN MODULATE THE STABILITY AND BIODISTRIBUTION OF INTERLEUKIN-2
Authors:
- Hisataka KobayashiHKHisataka Kobayashi
- Yutaka TagayaYTYutaka Tagaya
- Eui-Sik HanEHEui-Sik Han
- In-Sook KimIKIn-Sook Kim
- Nhat LeNLNhat Le
- Chang H PaikCPChang H Paik
- Ira PastanIPIra Pastan
- David L NelsonDNDavid L Nelson
- Thomas A WaldmannTWThomas A Waldmann
- Jorge A CarrasquilloJCJorge A Carrasquillo
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Consensus symposium on combined antiviral therapy; Overview of interferon and IL-2 combinations for the treatment of HIV infectionAntiviral Research, 1996
- Targeted Inactivation of the Mouse α2-Macroglobulin GeneJournal of Biological Chemistry, 1995
- G-CSF in the Biology and Treatment of Acute Myeloid LeukemiasLeukemia & Lymphoma, 1995
- The Clinical Experience with Interleukin-2 in Cancer TherapyCancer Biotherapy, 1994
- Enhancement of anti-tumor activity of recombinant interleukin-2 (rIL-2) by immunocomplexing with a monoclonal antibody against rIL-2Biotherapy, 1993
- Evidence that natural murine soluble interleukin 4 receptors may act as transport proteins.Journal of Experimental Medicine, 1991
- Interactions between cytokines and α2-macroglobulinImmunology Today, 1990
- Soluble interleukin‐2 receptors in systemic lupus erythematosusArthritis & Rheumatism, 1988
- Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycolurilBiochemical and Biophysical Research Communications, 1978
- Insulin in blood and insulin antibodiesThe American Journal of Medicine, 1966